Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

STREPTOMYCIN SULFATE

STREPTOMYCIN SULFATE

Standard Dose
EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview STREPTOMYCIN SULFATE is listed in Drugs@FDA under application 060076 (ANDA).

Marketing status: Discontinued Active ingredient STREPTOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 1989-08-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview STREPTOMYCIN SULFATE is listed in Drugs@FDA under application 060076 (ANDA). Marketing status: Discontinued Active ingredient STREPTOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 1989-08-03 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
STREPTOMYCIN SULFATE (STREPTOMYCIN SULFATE) | Drug Monograph | MedicHelpline